Description
+ Include: 18 videos + 19 pdfs, size: 1.15 GB
+ Target Audience: oncologist
+ Sample video: contact me for sample video
+ Information:
- Start date 01 Sep 2023
- End date 02 Sep 2023
- Location Barcelona, Spain
Learning objectives
- To understand the biology of specific oncogene addicted NSCLC and the rationale for targeted treatment
- To review the targeted treatment strategies, including current approvals and ongoing trials, in patients with oncogene addicted NSCLC
- To learn about the best current practice regarding testing methodology and get an outlook on future developments
- To improve interdisciplinary collaboration between oncology and pathology by understanding individual challenges in testing and treatment
- To understand health-economical aspects of targeted treatment in NSCLC
+ Topics:
Programme.pdf
Session 1 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board.mp4
Session 1 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board.pdf
Session 1 Biology of the Target Biomarker (Function and Roles in Normal and Tumour Tissue Homeostasis).mp4
Session 1 Biology of the Target Biomarker (Function and Roles in Normal and Tumour Tissue Homeostasis).pdf
Session 1 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation).mp4
Session 1 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation).pdf
Session 1 Update on the Clinical Efficacy of Approved Targeted Agents Formal Indications, Efficacy and Toxicity.mp4
Session 1 Update on the Clinical Efficacy of Approved Targeted Agents Formal Indications, Efficacy and Toxicity.pdf
Session 2 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board.mp4
Session 2 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board.pdf
Session 2 Biology of the Target Biomarker (Function and Roles in Normal and Tumour Tissue Homeostasis).mp4
Session 2 Biology of the Target Biomarker (Function and Roles in Normal and Tumour Tissue Homeostasis).pdf
Session 2 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation).mp4
Session 2 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation).pdf
Session 2 Update on the Clinical Efficacy of Approved Targeted Agents Formal Indications, Efficacy and Toxicity.mp4
Session 2 Update on the Clinical Efficacy of Approved Targeted Agents Formal Indications, Efficacy and Toxicity.pdf
Session 3 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board.mp4
Session 3 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board.pdf
Session 3 Biology of the Target Biomarker (Function and Roles in Normal and Tumour Tissue Homeostasis).mp4
Session 3 Biology of the Target Biomarker (Function and Roles in Normal and Tumour Tissue Homeostasis).pdf
Session 3 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation).mp4
Session 3 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation).pdf
Session 3 Update on the Clinical Efficacy of Approved Targeted Agents Formal Indications, Efficacy and Toxicity.mp4
Session 3 Update on the Clinical Efficacy of Approved Targeted Agents Formal Indications, Efficacy and Toxicity.pdf
Session 4 Value Health Economics of Testing and Targeting (incl. MCBS, ESCAT Actionability, RWD).mp4
Session 4 Value Health Economics of Testing and Targeting (incl. MCBS, ESCAT Actionability, RWD).pdf
Session 5 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board.mp4
Session 5 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board.pdf
Session 5 Biology of the Target Biomarker (Function and Roles in Normal and Tumour Tissue Homeostasis).mp4
Session 5 Biology of the Target Biomarker (Function and Roles in Normal and Tumour Tissue Homeostasis).pdf
Session 5 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation).mp4
Session 5 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation).pdf
Session 5 Update on the Clinical Efficacy of Approved Targeted Agents Formal Indications, Efficacy and Toxicity.mp4
Session 5 Update on the Clinical Efficacy of Approved Targeted Agents Formal Indications, Efficacy and Toxicity.pdf
Welcome and Learning Objectives Introduction.mp4
Welcome and Learning Objectives Introduction.pdf
Reviews
There are no reviews yet.